Tumor vaccination after allogeneic bone marrow cell reconstitution of the non-myeloablatively conditioned tumor-bearing murine host

Tumor vaccination after allogeneic bone marrow cell reconstitution of the non-myeloablatively conditioned tumor-bearing murine host

Bibliographic Details
Main Author:	Zöller M
Format:	Article
Language:	English
Published:	BMC 2004-07-01
Series:	Cancer Cell International

Similar Items

Tumor vaccine strategies after allogeneic T-cell depleted bone marrow transplantation
by: Ferrara James L.M.
Published: (2002-01-01)

Development of murine model of allogeneic bone marrow transplantation and graft-versus-host disease
by: I. S. Moiseev, et al.
Published: (2016-12-01)

Reduced-intensity versus myeloablative allogeneic transplantation
by: Daniel J. Weisdorf
Published: (2017-12-01)

Splenocytes seed bone marrow of myeloablated mice: implication for atherosclerosis.
by: Lai Wang, et al.
Published: (2015-01-01)

Immune reconstitution in humans following allogenic T-lymphocite-depleted bone marrow transplantation
by: Wimperis, J. Z.
Published: (1987)

Correction: Splenocytes Seed Bone Marrow of Myeloablated Mice: Implication for Atherosclerosis.
by: PLOS ONE Staff
Published: (2015-01-01)

Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation
by: Peter M. Schmid, et al.
Published: (2017-08-01)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
by: Erden Atilla, et al.
Published: (2017-02-01)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
by: Peter van Balen, et al.
Published: (2018-02-01)

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
by: Sydney X Lu, et al.
Published: (2011-01-01)

Reduced Intensity versus Full Myeloablative Conditioning in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
by: Kamran Alimoghaddam, et al.
Published: (2011-09-01)

Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation
by: Maite Alvarez, et al.
Published: (2021-01-01)

In vitro-activated tumor-bearing host T cells and the effectiveness of tumor vaccine immunotherapy
by: Qi-ling Li, et al.
Published: (2012-03-01)

Reconstituição imunológica após o transplante de medula óssea alogênico Immunology reconstitution after allogeneic bone marrow transplantation
by: Maria A. L. Reis, et al.
Published: (2004-01-01)

Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.
by: Luis A Sanchez-Perez, et al.
Published: (2013-01-01)

Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
by: Thomas Rea Wittenborn, et al.
Published: (2021-01-01)

Effects of Myeloablation, Peripheral Chimerism, and Whole-Body Irradiation on the Entry of Bone Marrow-Derived Cells into the Brain
by: Antoine Lampron, et al.
Published: (2012-06-01)

Clinical Evaluation of Allogeneic Bone Marrow-derived Dendritic Cells/Tumor Fusion Hybrids in Canine Cancers
by: Chien-Chun Pai, et al.
Published: (2008)

Immune reconstitution post bone marrow transplantation
by: Davison, Glenda Mary
Published: (2014)

Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation.
by: Seiichiro Higo, et al.
Published: (2014-01-01)

Bone marrow-derived host cells in murine cardiac allografts
by: Rezai, Nana
Published: (2010)

Semi-allogeneic vaccines and tumor-induced immune tolerance
by: Kindy Mark S, et al.
Published: (2009-01-01)

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation
by: I. A. Lisukov, et al.
Published: (2014-07-01)

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation
by: I. A. Lisukov, et al.
Published: (2014-07-01)

An investigation of interleukin-1 in graft versus host disease following allogeneic bone marrow transplantation
by: Cullup, Hannah
Published: (2002)

Chronic Graft versus Host Disease after Allogeneic Bone Marrow Transplantation; An Analysis of Incidence and Risk Factors.
by: Ghavamzadeh A, et al.
Published: (2004-07-01)

Chronic Graft versus Host Disease after Allogeneic Bone Marrow Transplantation; An Analysis of Incidence and Risk Factors.
by: A Ghavamzadeh, et al.
Published: (2004-03-01)

Modeling gene therapy of beta-Thalassemia : an evaluation of sub-lethal myeloablation and bone marrow transplantation as a curative approach
by: Cavilla, Benjamin
Published: (2009)

Modeling gene therapy of beta-Thalassemia : an evaluation of sub-lethal myeloablation and bone marrow transplantation as a curative approach
by: Cavilla, Benjamin
Published: (2009)

Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Desmoplastic Small Round Cell Tumor
by: Christopher J. Forlenza, et al.
Published: (2015-01-01)

Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation.
by: Elizabeth A de Kort, et al.
Published: (2019-01-01)

Transplantation of allogenic bone marrow in chronic myeloid leukemias
by: L S Lyubimova, et al.
Published: (2004-07-01)

RESULTS OF ALLOGENIC BONE MARROW TRANSPLANTATION IN CML IN IRAN
by: A. khodabeh., et al.
Published: (1998-07-01)

RESULTS OF ALLOGENIC BONE MARROW TRANSPLANTATION IN CML IN IRAN
by: A. khodabeh., et al.
Published: (1998-06-01)

Bacterial infections in the early period after allogeneic bone marrow transplantation
by: V N Vavilov, et al.
Published: (2015-07-01)

Cytokine Cocktail Promotes Alveolar Macrophage Reconstitution and Functional Maturation in a Murine Model of Haploidentical Bone Marrow Transplantation
by: Chao Hong, et al.
Published: (2021-09-01)

Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation
by: T A Bykova, et al.
Published: (2013-08-01)

Bone marrow transplantation concurrently reconstitutes donor liver and immune system across host species barrier in mice.
by: Ziping Qi, et al.
Published: (2014-01-01)

Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity
by: Fayun Zhang, et al.
Published: (2021-01-01)

Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome
by: Sagar S. Patel, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_o9u71is1jdml0nc95iaqnc2oho